A discussion with Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular research and advanced education at MedStar Heart Institute, and professor of medicine (cardiology) at Georgetown University. He explained the ongoing clinical trials using near infrared spectroscopy to detect lipid rich plaque in the coronary arteries. He spoke to DAIC at the 2018 American College of Cardiology (ACC) meeting.
VIDEO: How to Treat CTOs and Complex PCI Cases
A discussion with Khaldoon Alaswad, M.D., director, cardiac catheterization lab, Henry Ford Hospital, on treating chronic total occlusions (CTOs) and other complex PCI cases. Watch the VIDEO: Treating Chronic Total Occlusions with Bill Lombardi, M.D., director of complex coronary artery interventions at the University of Washington. Read the article "How to Tackle Coronary CTOs."
James Januzzi, M.D., Roman W. DeSanctis Endowed Distinguished Clinical Scholar in Medicine, and director of the Dennis and Marilyn Barry Fellowship in cardiology research at Massachusetts General Hospital, discusses the use of highly sensitive troponin testing for chest pain in the emergency department (ED). Read the related articles New Heart Attack Evaluation Cuts Unnecessary Tests, Time in ER and Highly-sensitive Troponin Test Can Detect Myocardial Injury After Non-Cardiac Surgery.
David Lanfear M.D., FACC, head of advanced heart failure and cardiac transplantation, Henry Ford Hospital, Detroit, discusses LVAD support technologies at the 2018 American College of Cardiology (ACC) meeting. Read the article “Device Technologies to Reduce Heart Failure Readmissions.” Watch the VIDEO “Technologies to Reduce Heart Failure Readmissions,” an interview with William Abraham, M.D., The Ohio State University Wexner Medical Center.
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at the 2018 meeting of the American College of Cardiology (ACC). Find links to other videos and the ACC 2018 Late-Breaking Trials.
A discussion with Doreen DeFaria Yeh, M.D., associate director, Massachusetts General Hospital Adult Congenital Heart Disease Program and MGH Cardiovascular Disease and Pregnancy Service, at the 2018 American College of Cardiology (ACC) meeting. Read the article “Diagnostic Differences in Women’s Heart Health.” Watch the VIDEO “Creating a Cardio-Obstetrics Team.”
A discussion with Ami Bhatt, M.D., director of the adult congenital heart program and outpatient cardiology, Massachusetts General Hospital, at the 2018 American College of Cardiology (ACC) meeting. Here is some additional related content on adult congenital heart disease:
Insights from the STS/ACC TVT Transcatheter Valve Registry, presented at the American College of Cardiology (ACC) 2018 meeting by Sammy Elmariah, M.D., MPH, interventional structural heart disease, Massachusetts General Hospital. See the following related content for other insights into transcatheter aortic valve replacement technology:
A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer, University of Michigan Health System, at the 2018 American College of Cardiology (ACC) meeting. For more information, read the article "Understanding Contrast-Induced Nephropathy."
Watch the VIDEO "Strategies to Avoid Acute Kidney Injury Caused by Cath Lab Contrast," an interview with Roxana Mehran, M.D.
An economic analysis of the DEFINE-FLAIR study comparing FFR vs. iFR, found a cost savings of nearly $900. The late-breaking session was presented at the 2018 American College of Cardiology (ACC) meeting by Manesh Patel, M.D., investigator and member of the study steering committee, and chief, division of cardiology, Duke University. Read more about the economic study. Watch a VIDEO on the 2017 results of the DEFINE-FLAIR and SWED-HEART iFR vs. FFR trials.
The Zoll LifeVest is a temporary, wearable defibrillator designed as a safety net for patients, especially those being evaluated for a permanent implantable cardioverter defibrillator (ICD). The Vest Prevention of Early Sudden Death Trial (VEST), presented at ACC 2018, was the first randomized, controlled, multi-center trial of the wearable cardioverter defibrillator. It looked to see if this device could effectively reduce sudden death in patients who had recently suffered a heart attack and had reduced heart function. Read more about the VEST Trial.
Sammy Elmariah, M.D., MPH, interventional structural heart disease, Massachusetts General Hospital, discusses the progression of using transcatheter heart valves to replace surgical valves at ACC.17. See the following related content for other insights into transcatheter aortic valve replacement technology:
This video details the first use of a new protocol at The Ohio State University’s Wexner Medical Center to start sudden cardiac arrest patients on extracorporeal membrane oxygenation (ECMO) en route to the hospital, where they are sent straight to the cath lab. According to the hospital, the protocol has improved cardiac arrest survival rates from 0 to nearly 40 percent. Video courtesy of The Ohio State University Wexner Medical Center.
The father of transradial artery access, Ferdinand Kiemeneij, M.D., Ph.D., interventional cardiologist, The Netherlands, explains how and why he first implemented the use of radial access and explains how the technique expanded beyond his cath lab to spread around the world. Read the article "Transradial Access Celebrates 25 Years". Watch the VIDEO "New Frontiers in Radial Access." Keep up to date on radial access news with DAIC's radial access channel.
DAIC Editor Dave Fornell previews the launch of augmented reality (AR) technology in the March/April 2018 issue of DAIC. Augmented reality brings new depth to print content through your smartphone by connecting to related videos and other resources.
American Heart Association (AHA) released a scientific statement Feb. 1, 2018, linking breast cancer and cardiovascular disease. Laxmi Mehta, M.D., author of the scientific statement and director of the Women’s Cardiovascular Health Program at The Ohio State University Wexner Medical Center, discusses a case from her center as an example of how the subspecialty of cardio-oncology is helping patients.
Take a video tour of some of the medical devices designed to improve patient care, improve patient engagement and increase physiologic monitoring highlighted at the 2018 Consumer Electronics Show (CES). One of the most interesting technologies is a flexible electronics ECG monitor that can bend and twist with the skin and interfaces with a smartphone app. The exhibition includes more than 3,000 vendors and more than 170,000 attendees. For more examples of future healthcare technologies, watch the VIDEO “Editor's Choice of Future Healthcare Technologies at HIMSS.”
Doreen DeFaria Yeh, M.D., associate director, MGH Adult Congenital Heart Disease Program, and co-director, MGH Cardiovascular Disease and Pregnancy Service, explains the role of a cardio-obstetrics team in caring for pregnant patients and the elements of building a strong program at ACC.17.
Find more women's health cardiac-related content in DAIC's Women's Health website channel.
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif., and former cardiology department manager at the cardiac cath lab at the Jesse Brown VA Medical Center in Chicago, offers insights from her SCAI Boot Camp presentation at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. She discusses implementing new techniques and technologies, drawing from her experience implementing radial access programs. Here are links to a couple articles she wrote on the topic “Tips When Prepping for Radial Procedures” and “How to Contend With Transradial Artery Perforation.”
Adam Greenbaum, M.D., co-director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, explains how his center is already performing off-label transcatheter mitral valve implantations in patients who otherwise have no more options. He also discusses some of the new transcatheter mitral valve technologies in development. Watch the VIDEO “Mitral and Tricuspid Valve Repair Technologies.” Watch a VIDEO of Greenbaum explaining his use of venous-to-aortic transcaval access in TAVR.
ITN and DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies on the expo floor at the 2017 Radiological Society of North America (RSNA) meeting. Watch the editor’s choice video for new health IT technologies at HIMSS 2017, new advances in cardiac ultrasound at ASE 2017, and CT advances at the SCCT 2017 meeting.
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pittsburgh Medical Center, explains the new mobile application he developed, which lets users visually model the forces at work during an MRI exam on patients with implanted medical devices, at the 2017 Radiological Society of North America (RSNA) meeting.
Read the related article “The Changing Relationship Between MRIs and Pacemakers.”
Dianna Bardo M.D., director of body MR and co-director of the 3-D Innovation Lab at Phoenix Children's Hospital, discusses how 3-D printing and other advanced imaging modalities can help improve outcomes in complex cases. Read the article “The Use of 3-D Printing in Cardiology.” Watch the WEBINAR “Innovation and Success in 3D-inspired Development of the Business and Clinical Practice,” presented by Bardo.
Shimadzu demonstrated its Trinias Interventional X-ray System at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. The system offers several features to enable improved patient access and procedural guidance at a lower radiation dose than previous generation angiography systems. For more information visit www.shimadzu.com/med/products/angio.
Mladen I. Vidovich, M.D., FACC, FSCAI, chief, section of cardiology, Jesse Brown VA Medical Center, Chicago, and associate professor of medicine at the University of Illinois at Chicago, discusses some of the current techniques and issues involved with radial artery access. DAIC spoke to him at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. Read articles he authored, including “Radiation Exposure Related to Transradial Access” and “Vascular Closure Devices Aid Closure of Large Access Sites.”
Dee Dee Wang, M.D., Director, Structural Heart Imaging at Henry Ford Hospital, Detroit, explains how her center uses 3-D printing and computer aided design (CAD) software to improve patient outcomes. She spoke to DAIC at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read the articles “The Use of 3-D Printing in Cardiology” and “Henry Ford Hospital Study Shows 3-D Imaging Improves Fixing Broken Hearts.”
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morristown Medical Center, part of Atlantic Health System, explains his experience with the Tryton Side Branch stent in both clinical practice and as an investigator in the Tryton Pivotal IDE Trial. Read the article “Data Published for Pivotal Trial for Tryton Side Branch Stent,” and about the regulatory clearance “FDA Clears First Dedicated Coronary Bifurcation Stent.”
DAIC Editor Dave Fornell shows some of the innovations displayed on the expo floor at the 2017 Transcatheter Cardiovascular Therapeutics (TCT). Hear what Cardiovascular Research Foundation (CRF) President and CEO Juan Granada, M.D., feels are the hottest technologies to watch.
A discussion with William Fearon, M.D. director of interventional cardiology, Stanford University Medical Center, about the FAST-FFR Trial he is heading. It is comparing wire-based fractional flow reserve (FFR) to angiography image-derived FFR. The technology may open the door to wider use of FFR by eliminating costs, disruption and extra time in the cath lab workflow, the use of pressure wires and eliminate the need for adenosine. Watch a VIDEO on the early adoption of FFR-CT technology to assess chest pain patients.
Related FFRangio Content
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigator for the Lotus valve’s U.S. pivotal trial. He explains what the clinical data to date has been for this new transcatheter aortic valve replacement (TAVR) device, which will likely become the third available on the U.S. market. Read the article "Lotus TAVR System Shows Superior Efficacy to CoreValve in Global REPRISE III Trial."
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospital, N.Y., explains the latest Watchman left atrial appendage (LAA) occluder study data presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. Watch the VIDEO “Post-FDA Approval Experience of LAA Occluders,” with David Holmes, M.D. Watch a VIDEO interview with Reddy at Heart Rhythm Society (HRS) 2017 on leadless pacing technologies.
A discussion with Peter L. Duffy, M.D., MMM, FACC, FSCAI CPE, interventional cardiologist and former director of quality for the cardiovascular service line at FirstHealth of the Carolinas Reid Heart Institute, at Moore Regional Hospital in Pinehurst, N.C. Read the article with Duffy “Interventional Cardiologist Redefines Value for Everyday Medical Practice.” Read the article “Preparing Hospitals for Mandatory Medicare Cardiac Bundled Payments.”
A discussion with William W. O’Neill, M.D., medical director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, about the creation of a national initiative to start percutaneous hemodynamic support first before beginning revascularization. O’Neill started the Detroit Cardiogenic Shock Initiative with several hospitals in 2016 and saw a 50 percent drop in mortality. Read the article “Detroit Cardiogenic Shock Initiative Goes National at TCT 2017.” Watch the VIDEO “Cardiogenic Shock Supported With Impella Shows Good Outcomes.”
John Rhodes, M.D., co-director of the adult congenital heart program, Medical University of South Carolina, is the principal investigator for the REDUCE Trial, the FDA pivotal study using the Cardioform for PFO closure to prevent cryptogenic stroke. He discusses some of the data showing benefit for patients and debate around all the trials for PFO closure.
Read about the results of the REDUCE trial in the article “PFO Closure Shows Positive Results from REDUCE Clinical Study.” Read about the approval of the first PFO closure device in 2016. Watch the VIDEO "Addressing Adult Congenital Heart Referrals."
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on what technologies he predicts will become main stream therapies in the coming years. DAIC spoke to him at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. Read the article “The Future of Cardiology: 17 Technologies to Watch.” Watch other VIDEOS with Granada, “Transcatheter Mitral Valve Therapies in Development.” “The Evolution of TAVR Technology,” and “Bioresorbable Stent Failure Modes, Technique, Patient Selection and Future Development.”
Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the MAVERIC Trial six-month outcomes using the Arto System at a press conferences at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read more about the trial in the article “Arto System Shows Promise as Less-Invasive Therapy for Heart Failure Patients.” Watch a VIDEO interview with Worthley on “Drug-Filled Stents as an Alternative to Polymer Drug Carriers.”
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morristown Medical Center, part of Atlantic Health System, explains the EARLY TAVR trial evaluating the use of transcatheter aortic valve replacement compared to surveilLance for patients With asymptomatic severe aortic stenosis. Genereux is the principal investigator for the trial. Read more about the EARLY TAVR trial.
A discussion with Ajay Kirtane, M.D., SM, director of the cardiac catheterization laboratories at New York-Presbyterian Hospital/Columbia University Medical Center, on the ABSORB III 3-year outcomes and other Absorb data presented at TCT 2017. He explains more on the poor outcomes for the bioresorbable stent compared to the Xience metallic stent and procedural issues based on operator technique and experience. Read the article “Abbott Will End Sales of Absorb Bioresorbable Stent.” Watch the VIDEO “Bioresorbable Stent Comparable to Xience at Two Years, With Concerns,” with Stephen Ellis, M.D. Watch the VIDEO “Poor Outcomes for Bioresorbable Stents in Small Coronary Arteries,” with Gregg Stone, M.D.
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state of transcatheter mitral valve technologies in development and in trials. He is involved in some of these trials and was the principal investigator for the pivotal MitraClip trial. Watch the VIDEO “Transcatheter Mitral Valve Technology, Anatomical Challenges” with Juan Granada, M.D.. Read the articles “Advances and Future Directions for Transcatheter Valves,” and “Transcatheter Mitral Valve Replacement Devices in Development.”
Adam Greenbaum, M.D., co-director of the structural heart program at Henry Ford Health System in Detroit, discusses the innovative approach to transcatheter aortic valve replacement (TAVR) being pioneered at HFHS. Read the article "How to Perform Transcaval TAVR Access."
This video, provided by Acutus Medical, demonstrates a patient case showing the use of the AcQMap high-resolution electrophysiology (EP) mapping system. The system was cleared by the U.S. Food and Drug Administration (FDA) in October 2017. Read about the FDA approval. See more about this system in the VIDEO "Editor's Choice of Most Innovative New Technology at HRS 2017."